SHENZHEN, China, Sept. 7 /PRNewswire-Asia-FirstCall/ -- Mindray
Medical International Limited (NYSE: MR), a leading developer,
manufacturer and marketer of medical devices worldwide, today
announced the appointment of Mr. Minghe
Cheng as Chief Strategic Officer of the Company, effective
as of September 6, 2010. Mr. Cheng's
role will primarily include business model development, short and
long-term strategic program planning and corporate structure and
operation-process optimization.
"Mr. Cheng's extensive breadth of experience with Mindray's
strategy and development makes him the ideal choice for this
position," commented Mr. Xu Hang,
Mindray's Chairman and Co-Chief Executive Officer. "We are
confident that Mr. Cheng will continue to add value to Mindray's
brand and play an instrumental role in helping the company benefit
from new business and market opportunities."
"I look forward to my new role in developing both short and
long-term strategic plans for each of our existing product lines as
well as searching for new opportunities to aid the rapid and
healthy expansion of Mindray's overall business," added Mr.
Minghe Cheng. "There is great
potential for Mindray, and given our innovative approach and
strategic thinking backed by effective operations, we believe we
are well-positioned to capitalize on these new opportunities."
As a co-founder of Mindray, Mr. Cheng has served 17 years in
various roles across Mindray's sales, marketing and strategic
development departments since the Company's establishment. Mr.
Cheng received his bachelor's and master's degrees in biomedical
engineering from Shanghai Jiaotong University.
About Mindray
We are a leading developer, manufacturer and marketer of medical
devices worldwide. We maintain our global operational headquarters
in Shenzhen, China, and multiple
sales offices in major domestic and international markets. From our
main manufacturing and engineering base in China and through our worldwide distribution
network, we supply internationally a broad range of products across
three primary business segments, comprised of patient monitoring
and life support products, in-vitro diagnostic products and medical
imaging systems. For more information, please visit
http://ir.mindray.com .
For investor and media inquiries, please contact:
In the U.S.:
Bryan Armstrong
FD
Tel: +1-312-553-6707
Email: bryan.armstrong@fd.com
John Capodanno
FD
Tel: +1-212-850-5705
Email: john.capodanno@fd.com
In China:
Cathy Gao
Tel: +86-755-2658-2518
Email: ir@mindray.com
SOURCE Mindray Medical International Limited
Copyright t. 7 PR Newswire